- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02767258
Effect of Nursing Care on Prevention of Dry Eye
February 13, 2017 updated by: Diego Dias de Araújo
Randomized Clinical Trial: Effect of Nursing Interventions on Prevention of Dry Eye in Critically Ill Patients
Clinical trial for prevention, randomized controlled, parallel, double-blind, with three arms, which purpose is verify the nursing interventions (artificial tear gel and liquid artificial tears)effects to prevent dry eye in adult patients admitted in ICU.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Critically ill patients are at higher risk for dry eye and the mechanisms responsible for ocular lubrication and protection can be compromised.
However, the literature diverges on which is the best clinical practice for treatment.
Thus, the general objective of this study was to evaluate the risk for developing dry eye in critically ill patients and the effectiveness of three types of interventions: eye gel and eyedrops (control group).
The specific objectives were: verify the most effective intervention for the prevention of dry eye from the available literature and provided by: eye gel compared to the control group eyedrops who received eye care through randomized controlled clinical trial.
Patients and methods: This study is a randomized controlled trial to determine the best care for the prevention of dry eye from those available on the market (eye drops and eye gel), in the period from 14/01/2016 to 31/12/2019 .
The expected result is: negative values in Schirmer test and no corneal ulcers presence.
Study Type
Interventional
Enrollment (Anticipated)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minas Gerais
-
Montes Claros, Minas Gerais, Brazil, 39402-218
- Recruiting
- Santa de Misericórdia Montes Claros
-
Contact:
- Diego Dias de Araújo
- Phone Number: (38)3213-2150
- Email: diego.dias1508@gmail.com
-
Principal Investigator:
- Diego Dias de Araújo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 96 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Be over 18 years;
- Did not present dry eye at the time of admission;
- Stay in the ICU for at least 24 hours;
- Be in mechanical ventilation therapy;
- Glance less than 5 per minute;
- Comatose, sedated or Glasgow less than or equal to 7;
- Consent to participate in research or have.
Exclusion Criteria:
- Have not the responsabille authorization;
- Patients with severe eye disease or with history of adverse effects after use of any of the interventions proposed and not tolerate the treatment: artificial tear gel, artificial tear liquid and saline 0.9%.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Sham Comparator: Eye drop
Eye drop LACRIBELL® - two drops each eye, two times a day, after eye cleansing.
|
Hypromellose and dextran based eyedrop, used in the treatment of dry eye.
Other Names:
|
|
Experimental: VIDISIC® GEL
Ocular gel VIDISIC® GEL applied two times a day at the lower palpebra from medium line to the lateral border.
|
Carbomer based gel, used in the treatment of dry eye.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dry Eye
Time Frame: Five consecutive days
|
Interventions will be applied in both eyes of the patients from 12 to 12 hours for five consecutive days.
Schirmer test will be applyed to evaluate the lacrimal volume.
Fluorescein test will be applyed to evaluate the ocular surface.
|
Five consecutive days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Diego D Araújo, PhD student, State University of Montes Claros, Minas Gerais, Brazil
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2016
Primary Completion (Anticipated)
December 31, 2017
Study Completion (Anticipated)
December 31, 2019
Study Registration Dates
First Submitted
May 6, 2016
First Submitted That Met QC Criteria
May 9, 2016
First Posted (Estimate)
May 10, 2016
Study Record Updates
Last Update Posted (Actual)
February 14, 2017
Last Update Submitted That Met QC Criteria
February 13, 2017
Last Verified
February 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EE/UFMG
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
The study and the information provided will be confidential and used only for purposes of this research.
Disclosure of information will be anonymous and in conjunction with the responses of a group of people, never individually.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dry Eye Syndromes
-
Southern College of OptometryNot yet recruitingEye Diseases | Dry Eye | Chronic Dry Eye
-
Southern College of OptometryNot yet recruitingEye Diseases | Dry Eye | Dry Eye Syndromes | Dry Eyes Chronic
-
University of MiamiNot yet recruitingEye Diseases | Dry Eye | Eyes Dry ChronicUnited States
-
Neuro-Ophthalmology of TexasHarrow IncRecruiting
-
Vision Innovation Centers of Pennsylvania, LLC...Nordic Pharma, USARecruiting
-
Demaod LtdNot yet recruitingDry Eye | Dry Eye Syndromes
-
Eye & ENT Hospital of Fudan UniversityRecruiting
-
Singapore National Eye CentreThe Eye Hospital of Wenzhou Medical UniversityNot yet recruiting
-
The Hong Kong Polytechnic UniversityRecruitingDry Eye | Dry Eye Disease (DED)Hong Kong
-
Indiana UniversityRecruiting
Clinical Trials on LACRIBELL®
-
Hospital Risoleta Tolentino NevesConselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação de...CompletedKeratitis | Corneal UlcerBrazil
-
University of Campinas, BrazilCompletedCystoid Macular Edema Following Cataract Surgery, BilateralBrazil
-
Dong-A ST Co., Ltd.CompletedFunctional DyspepsiaKorea, Republic of
-
Galderma R&DCompletedAtopic DermatitisPhilippines, China
-
Chong Kun Dang PharmaceuticalCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedPertussis | Diphtheria | PolioUnited States
-
Chung-Ang University Hosptial, Chung-Ang University...UnknownFunctional DyspepsiaKorea, Republic of
-
Amir AzarpazhoohInstitut Straumann AGCompletedPeriodontal Inflammation | Crown LengtheningCanada
-
Novartis PharmaceuticalsCompletedPulmonary Disease, Chronic Obstructive (COPD)Argentina
-
GuerbetCompletedPrimary Brain TumorColombia, Korea, Republic of, United States, Mexico